CSPC Pharmaceutical Group Limited (CHJTF)

USD 0.64

(0.0%)

Total Assets Summary of CSPC Pharmaceutical Group Limited

  • CSPC Pharmaceutical Group Limited's latest annual total assets in 2023 was 6.52 Billion USD , up 8.68% from previous year.
  • CSPC Pharmaceutical Group Limited's latest quarterly total assets in 2024 Q1 was - USD , down -100.0% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported annual total assets of 6 Billion USD in 2022, up 10.16% from previous year.
  • CSPC Pharmaceutical Group Limited reported annual total assets of 5.44 Billion USD in 2021, up 18.52% from previous year.
  • CSPC Pharmaceutical Group Limited reported quarterly total assets of - USD for 2024 Q1, down -100.0% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported quarterly total assets of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Assets Chart of CSPC Pharmaceutical Group Limited (2023 - 2015)

Historical Annual Total Assets of CSPC Pharmaceutical Group Limited (2023 - 2015)

Year Total Assets Total Assets Growth
2023 6.52 Billion USD 8.68%
2022 6 Billion USD 10.16%
2021 5.44 Billion USD 18.52%
2020 4.59 Billion USD 21.7%
2019 3.77 Billion USD 12.12%
2018 3.36 Billion USD 22.28%
2017 2.75 Billion USD 44.75%
2016 1.9 Billion USD 8.97%
2015 1.74 Billion USD 0.0%

Peer Total Assets Comparison of CSPC Pharmaceutical Group Limited

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD 93.539%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD 93.144%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -12517.03%
Novartis AG 99.94 Billion USD 93.472%
PT Kalbe Farma Tbk. 1.75 Billion USD -270.948%